Literature DB >> 23232064

Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis.

Shoaib Afzal1, Stig E Bojesen, Børge G Nordestgaard.   

Abstract

BACKGROUND: Vitamin D deficiency has been implicated in decreased insulin secretion and increased insulin resistance, hallmarks of type 2 diabetes mellitus. We tested the hypothesis that low plasma 25-hydroxyvitamin D [25(OH)D] is associated with increased risk of type 2 diabetes in the general population.
METHODS: We measured 25(OH)D in 9841 participants from the general population, of whom 810 developed type 2 diabetes during 29 years of follow-up. Analyses were adjusted for sex, age, smoking status, body mass index, income, physical activity, HDL cholesterol, and calendar month of blood draw.
RESULTS: Lower 25(OH)D concentrations, by clinical categories or seasonally adjusted quartiles, were associated with higher cumulative incidence of type 2 diabetes (trend, P = 2×10(-7) and P = 4×10(-10)). Multivariable adjusted hazard ratios of type 2 diabetes were 1.22 (95% CI 0.85-1.74) for 25(OH)D <5 vs ≥20 μg/L and 1.35 (1.09-1.66) for lowest vs highest quartile. Also, the multivariable adjusted hazard ratio of type 2 diabetes for a 50% lower concentration of 25(OH)D was 1.12 (1.03-1.21); the corresponding hazard ratio for those ≤58 years old was 1.26 (1.15-1.41). Finally, in a metaanalysis of 16 studies, the odds ratio for type 2 diabetes was 1.50 (1.33-1.70) for the bottom vs top quartile of 25(OH)D.
CONCLUSIONS: We observed an association of low plasma 25(OH)D with increased risk of type 2 diabetes. This finding was substantiated in a metaanalysis.
© 2012 American Association for Clinical Chemistry

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23232064     DOI: 10.1373/clinchem.2012.193003

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  85 in total

Review 1.  A reappraisal of vitamin D effect on non-skeletal targets and mortality.

Authors:  S Minisola; C Cipriani; M Cilli; A Scillitani; J Pepe
Journal:  J Endocrinol Invest       Date:  2015-09-10       Impact factor: 4.256

Review 2.  Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism.

Authors:  Stefania Giuliana Garbossa; Franco Folli
Journal:  Rev Endocr Metab Disord       Date:  2017-06       Impact factor: 6.514

3.  The increased T helper cells proliferation and inflammatory responses in patients with type 2 diabetes mellitus is suppressed by sitagliptin and vitamin D3 in vitro.

Authors:  Elham Mahabadi-Ashtiyani; Vida Sheikh; Shiva Borzouei; Iraj Salehi; Mahdi Alahgholi-Hajibehzad
Journal:  Inflamm Res       Date:  2019-06-25       Impact factor: 4.575

4.  Vitamin D Receptor Gene Polymorphisms Are Associated with Abdominal Visceral Adipose Tissue Volume and Serum Adipokine Concentrations but Not with Body Mass Index or Waist Circumference in African Americans: The Jackson Heart Study.

Authors:  Rumana J Khan; Pia Riestra; Samson Y Gebreab; James G Wilson; Amadou Gaye; Ruihua Xu; Sharon K Davis
Journal:  J Nutr       Date:  2016-06-29       Impact factor: 4.798

Review 5.  Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis.

Authors:  Jennifer C Seida; Joanna Mitri; Isabelle N Colmers; Sumit R Majumdar; Mayer B Davidson; Alun L Edwards; David A Hanley; Anastassios G Pittas; Lisa Tjosvold; Jeffrey A Johnson
Journal:  J Clin Endocrinol Metab       Date:  2014-07-25       Impact factor: 5.958

Review 6.  Vitamin D and diabetes mellitus: Causal or casual association?

Authors:  M Grammatiki; E Rapti; S Karras; R A Ajjan; Kalliopi Kotsa
Journal:  Rev Endocr Metab Disord       Date:  2017-06       Impact factor: 6.514

Review 7.  Maternal-fetal impact of vitamin D deficiency: a critical review.

Authors:  Letícia Schwerz Weinert; Sandra Pinho Silveiro
Journal:  Matern Child Health J       Date:  2015-01

Review 8.  Vitamin D and diabetes.

Authors:  Joanna Mitri; Anastassios G Pittas
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

Review 9.  Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes.

Authors:  Vijay Shivaswamy; Brian Boerner; Jennifer Larsen
Journal:  Endocr Rev       Date:  2015-12-09       Impact factor: 19.871

10.  Serum 25-hydroxyvitamin D concentration does not independently predict incident diabetes in older women.

Authors:  A L Schafer; N Napoli; L Lui; A V Schwartz; D M Black
Journal:  Diabet Med       Date:  2014-01-08       Impact factor: 4.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.